Atlas Trials

Zibotentan, an Endothelin Receptor Antagonist, Patients With Intermittent Claudication

Clinical trial NCT01890135 · COMPLETED

Trial details

NCT number
NCT01890135
Sponsor
University of Virginia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Peripheral Arterial DiseaseIntermittent Claudication
Start date
2013-06-01
Primary completion
2016-06-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.